Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation
© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America..
Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:72 |
|---|---|
| Enthalten in: |
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America - 72(2021), 8 vom: 26. Apr., Seite 1463-1466 |
| Sprache: |
Englisch |
|---|
| Links: |
|---|
| Themen: |
Coronavirus |
|---|
| Anmerkungen: |
Date Completed 30.04.2021 Date Revised 24.02.2023 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1093/cid/ciaa933 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM315555955 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM315555955 | ||
| 003 | DE-627 | ||
| 005 | 20231225155152.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1093/cid/ciaa933 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1051.xml |
| 035 | |a (DE-627)NLM315555955 | ||
| 035 | |a (NLM)32984870 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Toor, Jaspreet |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Predicted Impact of COVID-19 on Neglected Tropical Disease Programs and the Opportunity for Innovation |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.04.2021 | ||
| 500 | |a Date Revised 24.02.2023 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. | ||
| 520 | |a Due to the COVID-19 pandemic, many key neglected tropical disease (NTD) activities have been postponed. This hindrance comes at a time when the NTDs are progressing towards their ambitious goals for 2030. Mathematical modelling on several NTDs, namely gambiense sleeping sickness, lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiases (STH), trachoma, and visceral leishmaniasis, shows that the impact of this disruption will vary across the diseases. Programs face a risk of resurgence, which will be fastest in high-transmission areas. Furthermore, of the mass drug administration diseases, schistosomiasis, STH, and trachoma are likely to encounter faster resurgence. The case-finding diseases (gambiense sleeping sickness and visceral leishmaniasis) are likely to have fewer cases being detected but may face an increasing underlying rate of new infections. However, once programs are able to resume, there are ways to mitigate the impact and accelerate progress towards the 2030 goals | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, N.I.H., Extramural | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a coronavirus | |
| 650 | 4 | |a modeling | |
| 650 | 4 | |a neglected tropical diseases | |
| 700 | 1 | |a Adams, Emily R |e verfasserin |4 aut | |
| 700 | 1 | |a Aliee, Maryam |e verfasserin |4 aut | |
| 700 | 1 | |a Amoah, Benjamin |e verfasserin |4 aut | |
| 700 | 1 | |a Anderson, Roy M |e verfasserin |4 aut | |
| 700 | 1 | |a Ayabina, Diepreye |e verfasserin |4 aut | |
| 700 | 1 | |a Bailey, Robin |e verfasserin |4 aut | |
| 700 | 1 | |a Basáñez, Maria-Gloria |e verfasserin |4 aut | |
| 700 | 1 | |a Blok, David J |e verfasserin |4 aut | |
| 700 | 1 | |a Blumberg, Seth |e verfasserin |4 aut | |
| 700 | 1 | |a Borlase, Anna |e verfasserin |4 aut | |
| 700 | 1 | |a Rivera, Rocio Caja |e verfasserin |4 aut | |
| 700 | 1 | |a Castaño, María Soledad |e verfasserin |4 aut | |
| 700 | 1 | |a Chitnis, Nakul |e verfasserin |4 aut | |
| 700 | 1 | |a Coffeng, Luc E |e verfasserin |4 aut | |
| 700 | 1 | |a Crump, Ronald E |e verfasserin |4 aut | |
| 700 | 1 | |a Das, Aatreyee |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Christopher N |e verfasserin |4 aut | |
| 700 | 1 | |a Davis, Emma L |e verfasserin |4 aut | |
| 700 | 1 | |a Deiner, Michael S |e verfasserin |4 aut | |
| 700 | 1 | |a Diggle, Peter J |e verfasserin |4 aut | |
| 700 | 1 | |a Fronterre, Claudio |e verfasserin |4 aut | |
| 700 | 1 | |a Giardina, Federica |e verfasserin |4 aut | |
| 700 | 1 | |a Giorgi, Emanuele |e verfasserin |4 aut | |
| 700 | 1 | |a Graham, Matthew |e verfasserin |4 aut | |
| 700 | 1 | |a Hamley, Jonathan I D |e verfasserin |4 aut | |
| 700 | 1 | |a Huang, Ching-I |e verfasserin |4 aut | |
| 700 | 1 | |a Kura, Klodeta |e verfasserin |4 aut | |
| 700 | 1 | |a Lietman, Thomas M |e verfasserin |4 aut | |
| 700 | 1 | |a Lucas, Tim C D |e verfasserin |4 aut | |
| 700 | 1 | |a Malizia, Veronica |e verfasserin |4 aut | |
| 700 | 1 | |a Medley, Graham F |e verfasserin |4 aut | |
| 700 | 1 | |a Meeyai, Aronrag |e verfasserin |4 aut | |
| 700 | 1 | |a Michael, Edwin |e verfasserin |4 aut | |
| 700 | 1 | |a Porco, Travis C |e verfasserin |4 aut | |
| 700 | 1 | |a Prada, Joaquin M |e verfasserin |4 aut | |
| 700 | 1 | |a Rock, Kat S |e verfasserin |4 aut | |
| 700 | 1 | |a Le Rutte, Epke A |e verfasserin |4 aut | |
| 700 | 1 | |a Smith, Morgan E |e verfasserin |4 aut | |
| 700 | 1 | |a Spencer, Simon E F |e verfasserin |4 aut | |
| 700 | 1 | |a Stolk, Wilma A |e verfasserin |4 aut | |
| 700 | 1 | |a Touloupou, Panayiota |e verfasserin |4 aut | |
| 700 | 1 | |a Vasconcelos, Andreia |e verfasserin |4 aut | |
| 700 | 1 | |a Vegvari, Carolin |e verfasserin |4 aut | |
| 700 | 1 | |a de Vlas, Sake J |e verfasserin |4 aut | |
| 700 | 1 | |a Walker, Martin |e verfasserin |4 aut | |
| 700 | 1 | |a Hollingsworth, T Déirdre |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Clinical infectious diseases : an official publication of the Infectious Diseases Society of America |d 1992 |g 72(2021), 8 vom: 26. Apr., Seite 1463-1466 |w (DE-627)NLM012603007 |x 1537-6591 |7 nnns |
| 773 | 1 | 8 | |g volume:72 |g year:2021 |g number:8 |g day:26 |g month:04 |g pages:1463-1466 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1093/cid/ciaa933 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 72 |j 2021 |e 8 |b 26 |c 04 |h 1463-1466 | ||